High survival rate after two-stage resection of advanced colorectal liver metastases: Response-based selection and complete resection define outcome

Journal of Clinical Oncology

Volumn 29, Issue 8, 2011, Pages 1083-1090

  Brouquet, Antoine ^a   Abdalla, Eddie K ^a   Kopetz, Scott ^a   Garrett, Christopher R ^a   Overman, Michael J ^a   Eng, Cathy ^a   Andreou, Andreas ^a   Loyer, Evelyne M ^a   Madoff, David C ^a   Curley, Steven A ^a   Vauthey, Jean Nicolas ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; FLUOROURACIL; IRINOTECAN; OXALIPLATIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; COLORECTAL METASTASIS; FEMALE; FOLLOW UP; HUMAN; INTENTION TO TREAT ANALYSIS; KIDNEY FAILURE; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURVIVAL RATE; TUMOR VOLUME; WOUND INFECTION;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; FEMALE; HEPATECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PATIENT SELECTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TEXAS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 79952753550     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.32.6132     Document Type: Article

References (28)

1. Scheele J, Stang R, Altendorf-Hofmann A, et al: Resection of colorectal liver metastases. World J Surg 19:59-71, 1995
2. Abdalla EK, Vauthey JN, Ellis LM, et al: Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239:818-825, 2004
3. Kopetz S, Chang GJ, Overman MJ, et al: Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol 27:3677-3683, 2009
4. Blazer DG 3rd, Kishi Y, Maru DM, et al: Pathologic response to preoperative chemotherapy: A new outcome end point after resection of hepatic colorectal metastases. J Clin Oncol 26:5344-5351, 2008
5. Adam R, Laurent A, Azoulay D, et al: Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors. Ann Surg 232:777-785, 2000
6. Wicherts DA, Miller R, de Haas RJ, et al: Long-term results of two-stage hepatectomy for irresectable colorectal cancer liver metastases. Ann Surg 248:994-1005, 2008
7. Jaeck D, Oussoultzoglou E, Rosso E, et al: A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg 240:1037-1049, 2004; discussion 1049-1051
8. Chun YS, Vauthey JN, Ribero D, et al: Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: Perioperative safety and survival. J Gastrointest Surg 11:1498-1504, 2007; discussion 1504-1505
9. de Gramont A, Figer A, Seymour M, et al: Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18:2938-2947, 2000 (Pubitemid 30644117)
10. Douillard JY, Cunningham D, Roth AD, et al: Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: A multicentre randomised trial. Lancet 355:1041-1047, 2000 (Pubitemid 30162806)
11. Hurwitz H, Fehrenbacher L, Novotny W, et al: Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:2335-2342, 2004 (Pubitemid 38702844)
12. Van Cutsem E, Köhne CH, Hitre E, et al: Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med 360:1408-1417, 2009
13. Chun YS, Vauthey JN, Boonsirikamchai P, et al: Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases. JAMA 302:2338-2344, 2009
14. Elias D, Lefevre JH, Chevalier J, et al: Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol 27:681-685, 2009
15. Adam R, Pascal G, Castaing D, et al: Tumor progression while on chemotherapy: A contraindication to liver resection for multiple colorectal metastases? Ann Surg 240:1052-1061, 2004; discussion 1061-1064
16. Therasse P, Arbuck SG, Eisenhauer EA, et al: New guidelines to evaluate the response to treatment in solid tumors: European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205-216, 2000
17. Charnsangavej C, Clary B, Fong Y, et al: Selection of patients for resection of hepatic colorectal metastases: Expert consensus statement. Ann Surg Oncol 13:1261-1268, 2006 (Pubitemid 44435791)
18. Kishi Y, Madoff DC, Abdalla EK, et al: Is embolization of segment 4 portal veins before extended right hepatectomy justified? Surgery 144:744-751, 2008
19. Madoff DC, Abdalla EK, Gupta S, et al: Transhepatic ipsilateral right portal vein embolization extended to segment IV: Improving hypertrophy and resection outcomes with spherical particles and coils. J Vasc Interv Radiol 16:215-225, 2005 (Pubitemid 40322294)
20. Vauthey JN, Pawlik TM, Ribero D, et al: Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24:2065-2072, 2006 (Pubitemid 46622116)
21. Kishi Y, Zorzi D, Contreras CM, et al: Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases. Ann Surg Oncol 17:2870-2876, 2010
22. Chun YS, Laurent A, Maru D, et al: Management of chemotherapy-associated hepatotoxicity in colorectal liver metastases. Lancet Oncol 10:278-286, 2009
23. Dindo D, Demartines N, Clavien PA: Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205-213, 2004 (Pubitemid 38963009)
24. Tsai S, Marques HP, de Jong MC, et al: Two-stage strategy for patients with extensive bilateral colorectal liver metastases. HPB (Oxford) 12:262-269, 2010
25. Pamecha V, Nedjat-Shokouhi B, Gurusamy K, et al: Prospective evaluation of two-stage hepatectomy combined with selective portal vein embolisation and systemic chemotherapy for patients with unresectable bilobar colorectal liver metastases. Dig Surg 25:387-393, 2008
26. Kishi Y, Abdalla EK, Chun YS, et al: Three hundred and one consecutive extended right hepatectomies: Evaluation of outcome based on systematic liver volumetry. Ann Surg 250:540-548, 2009
27. Poultsides GA, Servais EL, Saltz LB, et al: Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. J Clin Oncol 27:3379-3384, 2009
28. Brouquet A, Mortenson MM, Vauthey JN, et al: Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: Classic, combined or reverse strategy? J Am Coll Surg 210:934-941, 2010